UiPath (PATH) director Philippe Botteri receives 19,175 RSU grant

Rhea-AI Filing Summary

Botteri Philippe reported acquisition or exercise transactions in this Form 4 filing.

UiPath, Inc. director Philippe Botteri received an equity grant of 19,175 Class A shares in the form of Restricted Stock Units (RSUs). The grant was made under UiPath’s non-employee director compensation policy and carries a grant price of $0.00 per share.

Each RSU represents the right to receive one Class A share upon settlement. The Annual Director RSUs vest in full on the earlier of the next year’s annual shareholder meeting (or immediately before that meeting if his board service ends then) or the first anniversary of the grant date, provided he continues serving as a director. Following this award, Botteri directly holds 3,180,064 Class A shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Botteri Philippe

Role null

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	19,175	$0.00	--

Holdings After Transaction: Class A Common Stock — 3,180,064 shares (Direct, null)

Footnotes (1)

1. This grant was made pursuant to the issuer's non-employee director compensation policy. Includes 19,175 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock upon settlement. Each Annual Director RSU vests on the earlier of the date of the following year's annual meeting (or the date immediately prior to the next annual meeting, if the non-employee director's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election), or the first anniversary of the date of grant, in each case subject to the director's continued service through such vesting date.

Key Figures

RSU grant size: 19,175 shares Grant price per share: $0.00 per share Holdings after transaction: 3,180,064 shares +1 more

4 metrics

RSU grant size 19,175 shares Annual Director RSU award

Grant price per share $0.00 per share Director RSU compensation grant

Holdings after transaction 3,180,064 shares Direct Class A Common Stock after grant

Vesting schedule Earlier of next annual meeting or 1-year anniversary Annual Director RSU vesting condition, service required

Key Terms

Restricted Stock Units (RSUs), non-employee director compensation policy, Annual Director RSU, Class A Common Stock

4 terms

Restricted Stock Units (RSUs) financial

"Includes 19,175 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

non-employee director compensation policy financial

"This grant was made pursuant to the issuer's non-employee director compensation policy."

Annual Director RSU financial

"Each Annual Director RSU vests on the earlier of the date of the following year's annual meeting"

Class A Common Stock financial

"Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock upon settlement."

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/29/2026 - 04:10 PM Accepted by SEC EDGAR 06/29/2026 - 04:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Botteri Philippe

(Last) (First) (Middle)

C/O UIPATH, INC., ONE VANDERBILT AVENUE

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UiPath, Inc. [ PATH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/25/2026		A(1)		19,175(2)	A	$0.00	3,180,064	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This grant was made pursuant to the issuer's non-employee director compensation policy.

2. Includes 19,175 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock upon settlement. Each Annual Director RSU vests on the earlier of the date of the following year's annual meeting (or the date immediately prior to the next annual meeting, if the non-employee director's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election), or the first anniversary of the date of grant, in each case subject to the director's continued service through such vesting date.

Remarks:

	/s/ Brad Brubaker, as Attorney-in-Fact	06/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did UiPath (PATH) director Philippe Botteri report in this Form 4?

Philippe Botteri reported receiving 19,175 Restricted Stock Units (RSUs) of UiPath Class A Common Stock. The award was granted at $0.00 per share under the company’s non-employee director compensation policy as part of his board compensation.

How many UiPath (PATH) shares did Philippe Botteri receive in this grant?

Philippe Botteri received 19,175 RSUs, each representing one share of UiPath Class A Common Stock. These RSUs are part of his annual director compensation and will convert into shares once they vest and are settled according to the award terms.

What are the vesting terms of Philippe Botteri’s UiPath (PATH) RSU award?

The 19,175 Annual Director RSUs vest on the earlier of next year’s annual shareholder meeting or the first anniversary of the grant date. Vesting is contingent on Botteri’s continued service as a UiPath non-employee director through the applicable vesting date.

How many UiPath (PATH) shares does Philippe Botteri hold after this transaction?

After the RSU grant, Philippe Botteri directly holds 3,180,064 shares of UiPath Class A Common Stock. This total includes the 19,175 RSUs reported in this filing, which will deliver shares upon settlement following satisfaction of the vesting conditions described.

Was Philippe Botteri’s UiPath (PATH) RSU award an open-market purchase?

No, the award was not an open-market purchase. It is a grant classified as an acquisition under code A, made pursuant to UiPath’s non-employee director compensation policy, with a grant price of $0.00 per share rather than a market transaction.